Abby P Douglas

11PUBLICATIONS
17CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursPredictive and prognostic markersInfectious diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 02, 2026
Invasive Fungal Disease in Allogeneic Hematopoietic Cell Transplantation: New Risk Factors and New Therapeutic Options in a Changing World.

Abby P Douglas, Monica A Slavin

|Sep 10, 2024
Preneutropenic Fever in Patients With Hematological Malignancies: A Novel Target for Antimicrobial Stewardship.

Jessica Chiodo-Reidy, Monica A Slavin, Shio Yen Tio

|Feb 02, 2024
Antimicrobial use and appropriateness in neutropenic fever: a study of the Hospital National Antimicrobial Prescribing Survey data.

Nikhil Singh, Abby P Douglas, Monica A Slavin

|Apr 11, 2023
Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool.

A Khanina, A P Douglas, D K Yeoh

|Feb 01, 2021
Quality of inpatient antimicrobial use in hematology and oncology patients.

Abby P Douglas, Lisa Hall, Rodney S James

|Feb 09, 2020
The QuantiFERON MonitorĀ® assay is predictive of infection post allogeneic hematopoietic cell transplantation.

Abby P Douglas, Lijia Yu, Vijaya Sundararajan

Pageof 2